Preliminary Line-Up of Presenters Set for 3rd Annual Stem Cell Summit
* Reuters is not responsible for the content in this press release.
Largest Gathering of Stem Cell Company Executives, Scientists, Investors and
Physicians on Feb. 26 in New York City
PHILADELPHIA, Jan. 15 /PRNewswire/ -- RRY Publications today announced the
preliminary line-up of presenters for the 3rd Annual Stem Cell Summit, which
is slated to bring together the largest gathering of stem cell company
executives, scientists, investors and physicians in New York City.
Participants will learn about the investment opportunities in the stem cell
marketplace, the groundbreaking stem cell products physicians are using today
and the growing market potential in terms of revenues.
The 3rd Annual Stem Cell Summit will take place on Feb. 26, 2008, at the
Hilton New York. Companies and products featured will include executives
from:
3DM, Inc. MG Biotherapeutics, LLC
Aastrom Biosciences, Inc. Neuronyx, Inc.
Aldagen, Inc. Novocell, Inc.
AllCells, LLC Orthofix International, N.V.
Arteriocyte, Inc. Osiris Therapeutics, Inc.
Athersys, Inc. PrimeGen Biotech LLC
BioE Corp. Progenitor Cell Therapy, LLC
Bioheart, Inc. Regenetech, Inc.
CellGenix Technologie Transfer GmbH ReNeuron Group plc
Cognate BioServices, Inc. SpineSmith Partners LP
Cytori Therapeutics, Inc. StemCyte, Inc.
Gamida Cell Ltd. Stemina, Inc.
Genzyme Corp. TiGenix NV
Geron Corp. Tissue Genesis, Inc.
Harvest Technologies Corp. Transition Therapeutics Inc.
INCELL Corp. LLC TriStem Corp.
MaxCyte, Inc. ViaCell, Inc.
MesoBlast Limited VistaGen Therapeutics, Inc.
In addition to the company and product overviews, Robin Young, president
of RRY Publications and the organizer of the annual Stem Cell Summit, will
provide an update on the 10-year market forecast for the industry. A lunch
panel of patients who have been treated with stem cells will discuss how the
use of stem cell products changed their lives.
"2008 is a year of major developments and advancements in stem cell
therapies," said Robin Young. "We expect to see the industry generating $100
million in revenue from stem cell product sales in 2008."
3rd Annual Stem Cell Summit Facts at a Glance
What: Largest Gathering of Stem Cell Company Executives,
Scientists, Investors and Physicians
When: Feb. 26, 2008
Where: Hilton New York
Trianon Ballroom
1335 Avenue of the Americas
Who: The Stem Cell Summit is organized by RRY Publications
Admission: $1,200 advance registration by Jan. 31, 2008
$1,500 at the door
Information: For more information on presentation or sponsorship
opportunities, call Lisa Carpenter at 877-817-6450 or send an e-mail to
lisa@ryortho.com. Additional information, including attendee registration
details, is available at www.stemcellsummit.com.
Sponsors: SpineSmith Partners LP
Orthofix International, N.V.
Blackstone Medical
Aastrom Biosciences, Inc.
Cytori Therapeutics, Inc.
Regenetech, Inc.
StemCyte, Inc.
TiGenix NV
Progenitor Cell Therapy, LLC
New York City Bioscience Initiative
Contacts: Wendy Lau
Russo Partners, LLC
212-845-4272
wendy.lau@russopartnersllc.com
SOURCE RRY Publications
Wendy Lau of Russo Partners, LLC for RRY Publications, +1-212-845-4272,
wendy.lau@russopartnersllc.com
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.



Follow Reuters